<i>DRD4, DRD2, DAT1,</i> and <i>ANKK1</i> Genes Polymorphisms in Patients with Dual Diagnosis of Polysubstance Addictions
<b>Background:</b> Approximately 25–50% of people diagnosed with substance use disorder experience psychiatric disorders, and this percentage is even higher if subclinical psychopathological symptomatology is taken into consideration. ”Dual diagnosis” implies the comorbidity of two disor...
Main Authors: | Jolanta Masiak, Jolanta Chmielowiec, Krzysztof Chmielowiec, Anna Grzywacz |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-11-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/9/11/3593 |
Similar Items
-
<i>DRD4</i> Exon 3 Gene Polymorphisms in Patients Diagnosed with Polysubstance Use Disorder and Co-Occurrence of a Depressive Episode
by: Krzysztof Chmielowiec, et al.
Published: (2021-11-01) -
Analysis of Selected Variants of <i>DRD2</i> and <i>ANKK1</i> Genes in Combat Athletes
by: Monika Michałowska-Sawczyn, et al.
Published: (2021-08-01) -
Significant association of DRD2 and ANKK1 genes with rural heroin dependence and relapse in men
by: Milena Lachowicz, et al.
Published: (2020-06-01) -
Dopamine Receptor DRD2 Gene rs1076560, Personality Traits and Anxiety in the Polysubstance Use Disorder
by: Aleksandra Suchanecka, et al.
Published: (2020-04-01) -
Analysis of Relationships between <i>DAT1</i> Polymorphism Variants, Personality Dimensions, and Anxiety in New Psychoactive Substance (Designer Drug) (NPS) Users
by: Jolanta Chmielowiec, et al.
Published: (2021-12-01)